I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase IIa trial of fingolimod for amyotrophic lateral scler..:
Berry, James D
;
Paganoni, Sabrina
;
Atassi, Nazem
...
qt5513221p. , 2017
Link:
https://escholarship.org/uc/item/5513221p
RT Journal T1
Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt5513221p&Exemplar=1&LAN=DE A1 Berry, James D A1 Paganoni, Sabrina A1 Atassi, Nazem A1 Macklin, Eric A A1 Goyal, Namita A1 Rivner, Michael A1 Simpson, Ericka A1 Appel, Stanley A1 Grasso, Daniela L A1 Mejia, Nicte I A1 Mateen, Farrah A1 Gill, Alan A1 Vieira, Fernando A1 Tassinari, Valerie A1 Perrin, Steven PB eScholarship, University of California YR 2017 K1 Adult K1 Aged K1 Amyotrophic Lateral Sclerosis: diagnosis K1 drug therapy K1 Bradycardia: chemically induced K1 Fatigue: chemically induced K1 Female K1 Fingolimod Hydrochloride: adverse effects K1 therapeutic use K1 Humans K1 Immunosuppressive Agents: adverse effects K1 Male K1 Middle Aged K1 Single-Blind Method JF qt5513221p LK http://dx.doi.org/https://escholarship.org/uc/item/5513221p DO https://escholarship.org/uc/item/5513221p SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)